- Art Cashin: Caution 'Growing' in Financials, Dividend Moves
- 3 Software Stock Picks from Lazard's Senior Analyst
- Investors Bet on a New Year's Rally For eBay
- Why You Should Play the Reflation Trade: Stock Picker
- S&P to Hit 1,200 by Year-End: Chief Investor
- 5 Big Bank Stocks Investors Should Consider: Strategists
- My 2010 Home Price Outlook: UBS Analyst
- Why Are Options Piling into Dollar Tree?
- Markets Can Rise 5-10% in the Near-Term: Strategist
- Buy These 'Competitively Positioned' Stocks: Portfolio Manager
MOST SHARED
- Ritz-Carlton ?Struggling? in the US: President
- The 'Real' Jobless Rate: 17.5% Of Workers Are Unemployed
- Obama Reiterates Commitment to Boost US-India Ties
- Half of Banks' Losses May Still Be Hidden: IMF Head
- Oil Price to Average $75.40 in 2010: Poll
- Americans Ditch Planes for Trains this Thanksgiving
- Starbucks Eyes China as Next Major Market
- NBA D-League On The Rise
- Jobless Claims Below 500,000, Durable Orders Slip
- Topless Business Is Taking Off
- 3 Software Stock Picks from Lazard's Senior Analyst
- Schork Oil Outlook: Gas Bulls Pinning Hopes on Mother Nature
- Toyota Makes Recall Fix And So Long Saab
- Investors Bet on a New Year's Rally For eBay
- Why You Should Play the Reflation Trade: Stock Picker
- Citi Mortgage Reveals What Treasury Won't
- S&P to Hit 1,200 by Year-End: Chief Investor
- Amended Berkshire Hathaway Filing Indicates No Secret Stock Stakes at End of Q3
- Consumer Mood Improves, But Anxiety Over Finances
- Jobless Claims Below 500,000, Durable Orders Slip
- AIG Board OKs CEO Pay; Benmosche Agrees to Stay
- Half of Banks' Losses May Still Be Hidden: IMF Head
- Garlic Price Rises Surpass Gold, Stocks in China
- Americans Ditch Planes for Trains this Thanksgiving
- Oil Price to Average $75.40 in 2010: Poll
- FDIC's Bair Cautions on Risks in Bank Break-Up Plan
- Call Me Crazy: Confessions of a Black Friday Shopper
RSS FEED
CNBC Stock Blog
Text Size 
Two strategists, Stephen Wood at Russell Investments and John Manley at Citi Smith Barney, shared their market rebound strategies with CNBC.
“Health care is a good place to be,” said Manley. “Biotech [stocks] are cheap, and some of the big pharmaceutical companies have done nothing good for eight years. [Although] there’s a general fear that you don’t want to own any stocks before an election, when I see a consensus that rock-hard, I think there may be an opposite side to it.”
Wood, however, disagreed with Manley.
“I’m not as convinced with the election trade as a lot of people are,” he said. “I’m waiting for a lot of specifics from both candidates, but making big bets based on an election year may not be a good idea.”
Disclosures:
Disclosure information for Stephen Wood and John Manley were not immediately available.
_________________________________
Top biotech names:
Biogen Idec [BIIB
Loading...
()
]
Genentech [DNA
Loading...
()
]
Amgen [AMGN
Loading...
()
]
Genzyme [GENZ
Loading...
()
]
Celgene [CELG
Loading...
()
]
_________________________________
Data is a real-time snapshot *Data is delayed at least 15 minutes